期刊文献+

精神科与心理咨询门诊焦虑障碍患者就诊情况分析 被引量:2

Analyses of patients with anxiety disorder in psychiatric vs. psychological counseling outpatient
暂未订购
导出
摘要 目的探讨焦虑障碍患者在心理咨询门诊和精神科门诊就诊情况,为焦虑障碍患者提供就诊指导.方法随机抽取2003年1月~2005年5月在上海市心理咨询中心和精神卫生中心门诊就诊的431例焦虑障碍患者的临床资料进行回顾性分析.结果心理咨询门诊焦虑障碍初诊患者(19.3%)明显高于精神科门诊(8.4%),且以年龄小、病程短、未婚、职员、科教文卫、离退休者为多.两门诊使用频率最高的抗焦虑剂为苯二氮[艹卓]类、5-羟色胺再摄取抑制剂.心理咨询门诊以心理干预或联合药物治疗者为多,脱失率60%;精神科门诊应用药物治疗者为多,脱失率30%,两门诊比较差异有极显著性(P<0.01).结论焦虑障碍患者在两门诊就诊特点的不同表现在人口学资料、干预措施及疗效等方面. Objective To analyze patients with anxiety disorder in psychiatric vs. psychological counseling outpatient in order to provide medical help-seeking advices for patients with anxiety disorder. Methods Clinical data of 431 randomly selected patients with anxiety disorder in outpatients of Shanghai Psychological Counseling Center and Mental Health Center from Jan. 2003 to May 2005 were retrospectively analyzed. Results Patients with first-diagnosis of anxiety in psychological counseling outpatient (19. 3%) were significantly more than in psychiatric outpatient(8.4%),their ages were younger and the course of diseases shorter, unmarried, clerks and retired. The commonest used drugs were benzodiazepines and SSRIs of both outpatients. Patients in psychological outpatient were mainly given the combination of psychointervention and drugs and lost-rate was 60%, ones in psychiatric outpatient were given pharmacotherapy and lost-rate was 30%, which showed significant difference between the 2 outpatients(P〈0.01). Conclusion The anxiety patients in the 2 outpatients had difference in demographic data, method of intervene, curative effect.
出处 《临床心身疾病杂志》 CAS 2006年第3期197-200,共4页 Journal of Clinical Psychosomatic Diseases
关键词 焦虑障碍 心理咨询门诊 精神科门诊 Anxiety disorder psychological counseling outpatient psychiatric outpatient
  • 相关文献

参考文献4

二级参考文献19

  • 1季建林,张明岛,储展明,严和.电话心理咨询的应用及评估[J].中国心理卫生杂志,1995,9(1):24-26. 被引量:37
  • 2沈渔村.开展精神疾病流行病学调查的重要意义[J].中华精神科杂志,1998,32(2):68-68.
  • 3Kessler RC, McGonogle DK, Zhao S, et al. Lifetime and 12-month prevalence of DSM-Ⅲ-R pschiatric disorders in the United States. Results from the National Comorbity Survey. Arch Gen Psychiatry,1994, 5: 8~19
  • 4Davidson JRT, Potts N, Richichi E. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol, 1993, 13:423~28
  • 5Gelernter CS, Uhde TW, Cimbolic P. Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry, 1991, 48: 938~945
  • 6Jitender Sareen, Murray Stein. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Drugs, 2000, 59(3): 497~509
  • 7Simpson BH, Schneier FR, Campeas RB. Imipramine in the treatment of social phobia. J Clin Psychopharmacol, 1998, 18(2): 135 ~5
  • 8Jonathan RT Davidson. Pharmacotherapy of social anxiety disorder. J Clin Psychiatry, 1998, 59 (suppl 17): 47~51
  • 9Viet IM van, Boer JA den. Psychopharmacological treatment of social phobia., a double-blind placebo-controlled study with fluvoxemine. Psychopharmacology, 1994, 115: 128~134
  • 10Stein MB, Fyer AJ. Fluvoxemine treatment of social phobia: a double-blind placebo-controlled study. American Journal of Psychiatry,1999, 156(5): 756~60

共引文献15

同被引文献7

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部